Pharma and Biotech Case Studies
Curated Regulatory Intelligence Augmented by AI
Pharma and Biotech
FDA Guidance on Developing Chimeric Antigen Receptor (CAR) T Cell Products …
The FDA’s latest guidance outlines crucial considerations for developing Chimeric Antigen Receptor (CAR) T cell...
Read morePharma and Biotech
Pharma Giant Leveraged RegASK to Proactively Monitor Regulatory Changes
The usage of dietary supplements and herbal medicine products continues to rise in several countries....
Read morePharma and Biotech
Boosting Claims for a Health Product Launch
Read the case study and learn how a major healthcare company successfully optimized their product...
Read morePharma and Biotech
Driving Pharmaceutical Regulatory Intelligence for Better Decision Making
Results The company gained increased visibility into the regulatory landscape impacting their product categories, along...
Read morePharma and Biotech
Anticipating Regulatory Risks and Opportunities in Consumer Health Industry
Read the case study and learn from this practical example how to anticipate regulatory risks...
Read morePharma and Biotech
Decentralized Clinical Trials: How CROs can benefit from our RegGuides
As the COVID-19 pandemic continues to disrupt clinical research, there is an increased need from...
Read morePharma and Biotech
How Real-World Evidence Supported Claim Substantiation on OTC Product in Eu…
A leader in the pharmaceutical industry wanted to leverage real-world evidence to bolster the claims...
Read morePharma and Biotech
Market Entry to Mexico for a Health Product
Demand: Evaluating the Likelihood of Product Certification in the Mexican Market A large Chinese...
Read more